![Report Czech Republic - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/czech-republic-non-antibiotic-non-hormone-non-alkaloid-medicaments-for-therapeutic-or-prophylactic-uses-market-analysis-forecast-size-trends-and-insights.webp)
Czech Republic - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingCzech Republic: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024
Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in the Czech Republic
In 2023, the Czech market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% to $X, rising for the fifth year in a row after two years of decline. Overall, consumption, however, posted a strong expansion. Consumption of peaked in 2023 and is likely to see steady growth in years to come.
Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in the Czech Republic
In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose notably to $X in 2023 estimated in export price. Overall, production, however, saw a strong expansion. The most prominent rate of growth was recorded in 2015 when the production volume increased by X%. Over the period under review, production of hit record highs in 2023 and is expected to retain growth in years to come.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Exports from the Czech Republic
In 2023, shipments abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second consecutive year after two years of growth. Overall, exports, however, saw a resilient increase. The growth pace was the most rapid in 2013 with an increase of X%. Over the period under review, the exports of attained the peak figure at X tons in 2017; however, from 2018 to 2023, the exports stood at a somewhat lower figure.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses surged to $X in 2023. In general, total exports indicated prominent growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports increased by X% against 2021 indices. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, the exports of hit record highs at $X in 2019; however, from 2020 to 2023, the exports stood at a somewhat lower figure.
Exports by Country
Slovakia (X tons), Denmark (X tons) and Germany (X tons) were the main destinations of exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from the Czech Republic, together accounting for X% of total exports. Bulgaria, Romania, Poland, the Netherlands, Spain and the UK lagged somewhat behind, together comprising a further X%.
From 2012 to 2023, the biggest increases were recorded for Romania (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, Slovakia ($X), Germany ($X) and Denmark ($X) were the largest markets for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exported from the Czech Republic worldwide, with a combined X% share of total exports. Bulgaria, Romania, the Netherlands, Poland, Spain and the UK lagged somewhat behind, together comprising a further X%.
In terms of the main countries of destination, Romania, with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2023, the average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, with an increase of X% against the previous year. In general, the export price saw a temperate expansion. The pace of growth appeared the most rapid in 2022 an increase of X%. Over the period under review, the average export prices attained the peak figure in 2023 and is expected to retain growth in the near future.
There were significant differences in the average prices for the major foreign markets. In 2023, amid the top suppliers, the country with the highest price was Germany ($X,051 per ton), while the average price for exports to the UK ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Romania (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Imports into the Czech Republic
In 2023, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses imported into the Czech Republic shrank notably to X tons, waning by X% on 2022 figures. Over the period under review, imports, however, posted moderate growth. The pace of growth appeared the most rapid in 2021 when imports increased by X% against the previous year. As a result, imports attained the peak of X tons. From 2022 to 2023, the growth of imports of remained at a lower figure.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2023. Overall, imports, however, showed a resilient expansion. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. As a result, imports reached the peak of $X. From 2022 to 2023, the growth of imports of remained at a lower figure.
Imports by Country
In 2023, Ireland (X tons) constituted the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses supplier to the Czech Republic, accounting for a X% share of total imports. Moreover, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from Ireland exceeded the figures recorded by the second-largest supplier, Slovakia (X tons), twofold. Switzerland (X tons) ranked third in terms of total imports with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of volume from Ireland stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Slovakia (X% per year) and Switzerland (X% per year).
In value terms, Slovakia ($X), Hungary ($X) and Germany ($X) appeared to be the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses suppliers to the Czech Republic, with a combined X% share of total imports.
In terms of the main suppliers, Hungary, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X per ton, picking up by X% against the previous year. In general, the import price saw a buoyant expansion. As a result, import price reached the peak level and is likely to continue growth in the immediate term.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Germany ($X,991 per ton), while the price for Ireland ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the Czech Republic. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Czech Republic
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the Czech Republic
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Asia.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the U.S..
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the EU.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
- Market Research in the Czech Republic
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses the Czech Republic
- Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses Market
- Frozen and Fresh or Chilled Skipjack Tuna Market
- Frozen Market
- Frozen Scallops Market
- Jellyfish Market
- Non-Citrus Fruits not Elsewhere Classified Market
- Battered Fish Fillet Market
- Fluorine, Chlorine, Bromine and Iodine Market